Establishes New Jersey Active Pharmaceutical Ingredient Regulatory Commission.

S 1161 creates the New Jersey Active Pharmaceutical Ingredient Regulatory Commission to oversee the manufacturing of active pharmaceutical ingredients (APIs) within the state. The commission, composed of 17 members including pharmaceutical industry experts, state health and economic development representatives, and non-voting legislative members, will establish manufacturing standards, promote the API industry's growth using federal resources, and serve as a liaison for industry access to federal funding. It will operate independently within the Department of the Treasury but must comply with federal law regarding API quality. This bill directly affects pharmaceutical manufacturers in New Jersey and aims to strengthen the state's regulatory framework for this sector.